US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist
  • 4.430
  • 0.0000.00%
Trading May 21 09:32 ET
374.96MMarket Cap-8860P/E (TTM)

Anavex Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-9.18%139.39M
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-1.94%149.16M
-1.94%149.16M
-2.77%153.2M
-Cash and cash equivalents
-9.18%139.39M
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-1.94%149.16M
-1.94%149.16M
-2.77%153.2M
Receivables
-20.11%3.79M
-13.32%3.55M
-15.16%2.71M
-15.16%2.71M
-66.99%2.17M
-26.76%4.74M
-23.78%4.09M
-65.05%3.19M
-65.05%3.19M
-23.73%6.56M
-Taxes receivable
-20.11%3.79M
-13.32%3.55M
-15.16%2.71M
-15.16%2.71M
-66.99%2.17M
-26.76%4.74M
-23.78%4.09M
-65.05%3.19M
-65.05%3.19M
-23.73%6.56M
Other current assets
37.00%1.35M
15.31%756K
84.46%653K
84.46%653K
79.14%827.57K
111.31%981.77K
73.51%655.64K
-4.82%354K
-4.82%354K
--461.96K
Total current assets
-9.22%144.52M
-0.20%148.07M
1.10%154.39M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
-5.51%152.71M
-5.51%152.71M
-3.72%160.22M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-9.22%144.52M
-0.20%148.07M
1.10%154.39M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
-5.51%152.71M
-5.51%152.71M
-3.72%160.22M
Liabilities
Current liabilities
Payables
-40.69%3.73M
-18.84%4.29M
12.99%4.32M
12.99%4.32M
32.81%4.15M
138.68%6.28M
14.10%5.29M
-19.30%3.83M
-19.30%3.83M
-25.13%3.13M
-accounts payable
-40.69%3.73M
-18.84%4.29M
12.99%4.32M
12.99%4.32M
32.81%4.15M
138.68%6.28M
14.10%5.29M
-19.30%3.83M
-19.30%3.83M
-25.13%3.13M
Current accrued expenses
-18.39%4.29M
-5.05%5.5M
27.72%5.94M
27.72%5.94M
0.18%5.03M
17.09%5.25M
36.49%5.79M
5.31%4.65M
5.31%4.65M
7.97%5.02M
Current deferred liabilities
0.03%917K
0.03%917K
106.53%917K
106.53%917K
106.56%916.76K
106.56%916.76K
106.56%916.76K
0.04%444K
0.04%444K
0.00%443.83K
Current liabilities
-31.83%9.56M
-5.68%12.5M
22.71%12.53M
22.71%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
-5.41%10.21M
-5.41%10.21M
2.27%9.48M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-31.83%9.56M
-5.68%12.5M
22.71%12.53M
22.71%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
-5.41%10.21M
-5.41%10.21M
2.27%9.48M
Shareholders'equity
Share capital
4.69%84K
5.08%82K
5.13%82K
5.13%82K
4.42%81.39K
3.98%80.24K
2.46%78.03K
2.74%78K
2.74%78K
3.72%77.94K
-common stock
4.69%84K
5.08%82K
5.13%82K
5.13%82K
4.42%81.39K
3.98%80.24K
2.46%78.03K
2.74%78K
2.74%78K
3.72%77.94K
-Preferred stock
----
----
----
----
----
--0
----
----
----
--0
Retained earnings
-14.94%-312.24M
-16.69%-301.69M
-19.35%-293.07M
-19.35%-293.07M
-22.33%-282.92M
-24.09%-271.64M
-24.02%-258.54M
-24.28%-245.56M
-24.28%-245.56M
-24.43%-231.27M
Paid-in capital
7.35%447.35M
11.08%437.18M
12.08%434.84M
12.08%434.84M
12.48%429.6M
12.19%416.73M
10.94%393.58M
11.38%387.98M
11.38%387.98M
11.37%381.93M
Other equity interest
---234K
----
----
----
----
----
----
----
----
----
Total stockholders'equity
-7.03%134.96M
0.33%135.58M
-0.45%141.85M
-0.45%141.85M
-2.64%146.75M
-4.63%145.17M
-7.68%135.12M
-5.52%142.49M
-5.52%142.49M
-4.08%150.74M
Total equity
-7.03%134.96M
0.33%135.58M
-0.45%141.85M
-0.45%141.85M
-2.64%146.75M
-4.63%145.17M
-7.68%135.12M
-5.52%142.49M
-5.52%142.49M
-4.08%150.74M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -9.18%139.39M0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M-4.98%143.62M-1.94%149.16M-1.94%149.16M-2.77%153.2M
-Cash and cash equivalents -9.18%139.39M0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M-4.98%143.62M-1.94%149.16M-1.94%149.16M-2.77%153.2M
Receivables -20.11%3.79M-13.32%3.55M-15.16%2.71M-15.16%2.71M-66.99%2.17M-26.76%4.74M-23.78%4.09M-65.05%3.19M-65.05%3.19M-23.73%6.56M
-Taxes receivable -20.11%3.79M-13.32%3.55M-15.16%2.71M-15.16%2.71M-66.99%2.17M-26.76%4.74M-23.78%4.09M-65.05%3.19M-65.05%3.19M-23.73%6.56M
Other current assets 37.00%1.35M15.31%756K84.46%653K84.46%653K79.14%827.57K111.31%981.77K73.51%655.64K-4.82%354K-4.82%354K--461.96K
Total current assets -9.22%144.52M-0.20%148.07M1.10%154.39M1.10%154.39M-1.50%157.81M-0.68%159.19M-5.43%148.37M-5.51%152.71M-5.51%152.71M-3.72%160.22M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -9.22%144.52M-0.20%148.07M1.10%154.39M1.10%154.39M-1.50%157.81M-0.68%159.19M-5.43%148.37M-5.51%152.71M-5.51%152.71M-3.72%160.22M
Liabilities
Current liabilities
Payables -40.69%3.73M-18.84%4.29M12.99%4.32M12.99%4.32M32.81%4.15M138.68%6.28M14.10%5.29M-19.30%3.83M-19.30%3.83M-25.13%3.13M
-accounts payable -40.69%3.73M-18.84%4.29M12.99%4.32M12.99%4.32M32.81%4.15M138.68%6.28M14.10%5.29M-19.30%3.83M-19.30%3.83M-25.13%3.13M
Current accrued expenses -18.39%4.29M-5.05%5.5M27.72%5.94M27.72%5.94M0.18%5.03M17.09%5.25M36.49%5.79M5.31%4.65M5.31%4.65M7.97%5.02M
Current deferred liabilities 0.03%917K0.03%917K106.53%917K106.53%917K106.56%916.76K106.56%916.76K106.56%916.76K0.04%444K0.04%444K0.00%443.83K
Current liabilities -31.83%9.56M-5.68%12.5M22.71%12.53M22.71%12.53M16.56%11.06M73.72%14.02M25.83%13.25M-5.41%10.21M-5.41%10.21M2.27%9.48M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -31.83%9.56M-5.68%12.5M22.71%12.53M22.71%12.53M16.56%11.06M73.72%14.02M25.83%13.25M-5.41%10.21M-5.41%10.21M2.27%9.48M
Shareholders'equity
Share capital 4.69%84K5.08%82K5.13%82K5.13%82K4.42%81.39K3.98%80.24K2.46%78.03K2.74%78K2.74%78K3.72%77.94K
-common stock 4.69%84K5.08%82K5.13%82K5.13%82K4.42%81.39K3.98%80.24K2.46%78.03K2.74%78K2.74%78K3.72%77.94K
-Preferred stock ----------------------0--------------0
Retained earnings -14.94%-312.24M-16.69%-301.69M-19.35%-293.07M-19.35%-293.07M-22.33%-282.92M-24.09%-271.64M-24.02%-258.54M-24.28%-245.56M-24.28%-245.56M-24.43%-231.27M
Paid-in capital 7.35%447.35M11.08%437.18M12.08%434.84M12.08%434.84M12.48%429.6M12.19%416.73M10.94%393.58M11.38%387.98M11.38%387.98M11.37%381.93M
Other equity interest ---234K------------------------------------
Total stockholders'equity -7.03%134.96M0.33%135.58M-0.45%141.85M-0.45%141.85M-2.64%146.75M-4.63%145.17M-7.68%135.12M-5.52%142.49M-5.52%142.49M-4.08%150.74M
Total equity -7.03%134.96M0.33%135.58M-0.45%141.85M-0.45%141.85M-2.64%146.75M-4.63%145.17M-7.68%135.12M-5.52%142.49M-5.52%142.49M-4.08%150.74M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg